Statistics for A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND)
Total visits
views | |
---|---|
A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND) | 122 |
Total visits per month
views | |
---|---|
August 2024 | 3 |
September 2024 | 4 |
October 2024 | 10 |
November 2024 | 4 |
December 2024 | 3 |
January 2025 | 0 |
February 2025 | 0 |
File Visits
views | |
---|---|
Chronic Diabetic Macular Edema.pdf(legacy) | 236 |
Chronic Diabetic Macular Edema.pdf | 3 |
Top country views
views | |
---|---|
United States | 50 |
China | 29 |
Portugal | 13 |
Australia | 11 |
India | 6 |
France | 3 |
Brazil | 2 |
Canada | 2 |
Germany | 2 |
Japan | 1 |
South Korea | 1 |
Sweden | 1 |
Top city views
views | |
---|---|
Durg | 1 |